Stock Market Update
20-Nov-25 14:30 ET
S&P 500 slides nearly 1%; Jacobs, Micron, Robinhood drag, Regeneron surges on FDA nod for Eylea HD
Dow -186.37
at 45952.19,
Nasdaq -304.36
at 22259.89,
S&P -65.25
at 6576.90
[BRIEFING.COM] The S&P 500 (-0.98%) is in second place on Thursday afternoon, down about 65 points.
Briefly, S&P 500 constituents Jacobs Solutions (J 129.25, -15.80, -10.89%), Robinhood Markets (HOOD 108.28, -9.88, -8.36%), and Micron (MU 204.97, -20.95, -9.27%) pepper the bottom of the standings. J falls due in part to its FY26 guidance coming in only modestly above expectations, with a low-end EPS miss and flat margin outlook, disappointing investors despite a small Q4 beat, while MU falls as SK Hynix (HXSCL) plans a big 2026 ramp in advanced DRAM output, stoking worries about future oversupply and pricing pressure in the memory market.
Meanwhile, Regeneron Pharma (REGN 741.27, +39.40, +5.61%) is among today's top performers after the FDA unexpectedly approved Eylea HD for RVO and monthly dosing, easing manufacturing-related regulatory fears and expanding the drug's market reach, which analysts say strengthens its position versus Vabysmo and supports a stronger growth outlook.
